Abstract | BACKGROUND: Although opioid analgesics have well-defined efficacy and safety in treatment of chronic cancer pain, further research is needed to define their role in treatment of chronic noncancer pain. OBJECTIVE: METHODS: One hundred thirty-three patients experiencing persistent osteoarthritis-related pain for at least 1 month were randomized to double-blind treatment with placebo (n = 45) or 10 mg (n = 44) or 20 mg (n = 44) of controlled-release oxycodone every 12 hours for 14 days. One hundred six patients enrolled in an open-label, 6-month extension trial; treatment for an additional 12 months was optional. RESULTS: Use of controlled-release oxycodone, 20 mg, was superior (P<.05) to placebo in reducing pain intensity and the interference of pain with mood, sleep, and enjoyment of life. During long-term treatment, the mean dose remained stable at approximately 40 mg/d after titration, and pain intensity was stable. Fifty-eight patients completed 6 months of treatment, 41 completed 12 months, and 15 completed 18 months. Common opioid side effects were reported, several of which decreased in duration as therapy continued. CONCLUSIONS: Around-the-clock controlled-release oxycodone therapy seemed to be effective and safe for patients with chronic, moderate to severe, osteo- arthritis-related pain. Effective analgesia was accompanied by a reduction in the interference of pain with mood, sleep, and enjoyment of life. Analgesia was maintained during long-term treatment, and the daily dose remained stable after titration. Typical opioid side effects were reported during short- and long-term therapy.
|
Authors | S H Roth, R M Fleischmann, F X Burch, F Dietz, B Bockow, R J Rapoport, J Rutstein, P G Lacouture |
Journal | Archives of internal medicine
(Arch Intern Med)
Vol. 160
Issue 6
Pg. 853-60
(Mar 27 2000)
ISSN: 0003-9926 [Print] United States |
PMID | 10737286
(Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Analgesics, Opioid
- Delayed-Action Preparations
- Oxycodone
|
Topics |
- Aged
- Analgesics, Opioid
(administration & dosage, adverse effects)
- Delayed-Action Preparations
- Double-Blind Method
- Female
- Humans
- Male
- Middle Aged
- Osteoarthritis
(complications)
- Oxycodone
(administration & dosage, adverse effects)
- Pain
(drug therapy, etiology)
- Severity of Illness Index
- Treatment Outcome
|